Preterm Neonates Clinical Trial
Official title:
Rate of Bronchopulmonary Dysplasia in Preterms Neonates Less Than 29 Weeks' Gestational Age and / or With Birth Weight Less Than 1000 g: a Double Blind Randomized Controlled Multicenter Trial Comparing SMOFlipid and Medialipide
SMOF is a large double blind placebo-controlled randomized clinical trial aiming to compare the rate of bronchopulmonary dysplasia (BPD) at 36 weeks corrected age in premature infants < 29 weeks and / or with birth weight < 1000 g receiving either SMOFlipid® or Medialipide® 20%. This study will offer new information for optimizing the management of preterms requiring parenteral nutrition. The investigators hypothesis is that the composition of SMOFlipid may decrease lipid peroxidation and oxidative stress in preterms, resulting in a lower incidence of BPD.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05957900 -
Neurobehavioral Responses to Multisensory Stimulation Module in Preterm Neonates
|
N/A | |
Completed |
NCT06173622 -
Effects of Fetal Positioning During Venipuncture
|
N/A | |
Completed |
NCT04122300 -
Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct
|
Phase 3 | |
Completed |
NCT03147846 -
The Hematologic Impact of Umbilical Cord Milking Versus Deferred Cord Clamping in Premature Neonates.
|
N/A | |
Recruiting |
NCT02798926 -
Polyethylene Bag: a Way of Preventing Hypothermia During Central Venous Catheter Placement in Preterm Neonates?
|
N/A | |
Completed |
NCT01215591 -
Trial of Weaning of Nasal Continuous Positive Airway Pressure (CPAP)
|
N/A | |
Completed |
NCT05892081 -
Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit
|
Phase 4 |